10-K Filing

ENZON PHARMACEUTICALS, INC. CIK: 727510 FY 2019

Filing Information

Form Type	10-K
Accession Number	`0001104659-20-022802`
Period End Date	20191231
Filing Date	20200219
Fiscal Year	2019
Fiscal Period	FY
XBRL Instance	enzn-20191231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 50 Income Statement 18 Cash Flow Statement 28 Stockholders Equity 9

Balance Sheet 50 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$5.45M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$6.50M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Milestone receivable	`MilestoneReceivableOnRoyaltiesCurrent`	$7.00M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Refundable tax credits receivable, current portion	`IncomeTaxesReceivable`	$970.00K	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Refundable tax credits receivable, current portion	`IncomeTaxesReceivable`	$485.00K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	170.00M	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$70.00K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$62.00K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	170.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$14.54M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$5.99M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	44.21M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	44.21M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	44.21M	shares	Point-in-time
Refundable tax credits receivable, net of current portion	`IncomeTaxesReceivableNoncurrent`	$970.00K	USD	Point-in-time
Refundable tax credits receivable, net of current portion	`IncomeTaxesReceivableNoncurrent`	$485.00K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	44.21M	shares	Point-in-time
Total assets	`Assets`	$6.48M	USD	Point-in-time
Total assets	`Assets`	$15.51M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$439.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$324.00K	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$78.00K	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$99.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$423.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$517.00K	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock - $0.01 par value, authorized 3,000,000 shares; no shares issued and outstanding at December 31, 2019 and 2018	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock - $0.01 par value, authorized 3,000,000 shares; no shares issued and outstanding at December 31, 2019 and 2018	`PreferredStockValue`	-	USD	Point-in-time
Common stock - $0.01 par value, authorized 170,000,000 shares; issued and outstanding 44,214,603 shares at December 31, 2019 and 2018	`CommonStockValue`	$442.00K	USD	Point-in-time
Common stock - $0.01 par value, authorized 170,000,000 shares; issued and outstanding 44,214,603 shares at December 31, 2019 and 2018	`CommonStockValue`	$442.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$75.69M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$83.65M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-69.10M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-70.08M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$9.14M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$6.05M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$14.99M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$15.51M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$6.48M	USD	Point-in-time

Income Statement 18 line items

Line Item	Tag	Value	Unit	Period
Royalties and milestones, net	`RoyaltyRevenueAndMilestones`	$6.92M	USD	Annual
Royalties and milestones, net	`RoyaltyRevenueAndMilestones`	$207.00K	USD	Annual
Total revenues	`Revenues`	$207.00K	USD	Annual
Total revenues	`Revenues`	$6.92M	USD	Annual
General and administrative	`OtherGeneralAndAdministrativeExpense`	$1.06M	USD	Annual
General and administrative	`OtherGeneralAndAdministrativeExpense`	$1.18M	USD	Annual
Total operating expenses	`OperatingExpenses`	$1.18M	USD	Annual
Total operating expenses	`OperatingExpenses`	$1.06M	USD	Annual
Operating (loss) income and (loss) income before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-973.00K	USD	Annual
Operating (loss) income and (loss) income before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$5.86M	USD	Annual
Income tax expense	`IncomeTaxExpenseBenefit`	$6.00K	USD	Annual
Income tax expense	`IncomeTaxExpenseBenefit`	$6.00K	USD	Annual
Net (loss) income	`NetIncomeLoss`	$-979.00K	USD	Annual
Net (loss) income	`NetIncomeLoss`	$5.85M	USD	Annual
Basic and diluted	`EarningsPerShareBasicAndDiluted`	$0.13	USD	Annual
Basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.02	USD	Annual
Basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	44.22M	shares	Annual
Basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	44.22M	shares	Annual

Cash Flow Statement 28 line items

Line Item	Tag	Value	Unit	Period
Net (loss) income	`NetIncomeLoss`	$-979.00K	USD	Annual
Net (loss) income	`NetIncomeLoss`	$5.85M	USD	Annual
Decrease (increase) in milestone receivable	`IncreaseDecreaseInMilestonesReceivable`	$7.00M	USD	Annual
Decrease (increase) in milestone receivable	`IncreaseDecreaseInMilestonesReceivable`	$-7.00M	USD	Annual
Decrease in other current assets	`IncreaseDecreaseInOtherOperatingAssets`	$-24.00K	USD	Annual
Decrease in other current assets	`IncreaseDecreaseInOtherOperatingAssets`	$-8.00K	USD	Annual
Decrease in refundable tax credit receivable	`IncreaseDecreaseInLongTermReceivablesCurrent`	-	USD	Annual
Decrease in refundable tax credit receivable	`IncreaseDecreaseInLongTermReceivablesCurrent`	$-970.00K	USD	Annual
(Decrease) increase in accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$-115.00K	USD	Annual
(Decrease) increase in accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$214.00K	USD	Annual
Increase (decrease) in accrued expenses and other current liabilities	`IncreaseDecreaseInOtherAccruedLiabilities`	$-65.00K	USD	Annual
Increase (decrease) in accrued expenses and other current liabilities	`IncreaseDecreaseInOtherAccruedLiabilities`	$21.00K	USD	Annual
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$6.91M	USD	Annual
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-978.00K	USD	Annual
Common stock dividends	`PaymentsOfDividendsCommonStock`	$7.96M	USD	Annual
Common stock dividends	`PaymentsOfDividendsCommonStock`	$5.31M	USD	Point-in-time
Common stock dividends	`PaymentsOfDividendsCommonStock`	-	USD	Annual
Common stock dividends	`PaymentsOfDividendsCommonStock`	$2.65M	USD	Point-in-time
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-7.96M	USD	Annual
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	-	USD	Annual
Net decrease in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-978.00K	USD	Annual
Net decrease in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-1.05M	USD	Annual
Cash at beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.45M	USD	Point-in-time
Cash at beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.48M	USD	Point-in-time
Cash at beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.50M	USD	Point-in-time
Cash at end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.45M	USD	Point-in-time
Cash at end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.48M	USD	Point-in-time
Cash at end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.50M	USD	Point-in-time

Stockholders Equity 9 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$9.14M	USD	Point-in-time
Balance	`StockholdersEquity`	$6.05M	USD	Point-in-time
Balance	`StockholdersEquity`	$14.99M	USD	Point-in-time
Net income (loss)	`NetIncomeLoss`	$-979.00K	USD	Annual
Net income (loss)	`NetIncomeLoss`	$5.85M	USD	Annual
Common stock dividend	`DividendsCommonStockStock`	$7.96M	USD	Annual
Balance	`StockholdersEquity`	$9.14M	USD	Point-in-time
Balance	`StockholdersEquity`	$6.05M	USD	Point-in-time
Balance	`StockholdersEquity`	$14.99M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.